Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,110 | -2,600 | -36,530 | -28,620 | -15,100 |
| Depreciation Amortization | 1,700 | 850 | 6,430 | 4,800 | 3,330 |
| Other Working Capital | -1,580 | -4,420 | -23,820 | -8,450 | -10,500 |
| Other Operating Activity | 520 | -30 | 14,370 | 6,640 | 1,090 |
| Operating Cash Flow | $-2,470 | $-6,200 | $-39,550 | $-25,630 | $-21,180 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -810 | -560 | -2,690 | -2,260 | -1,620 |
| Other Investing Activity | -3,420 | -7,080 | 53,400 | 60,410 | 39,420 |
| Investing Cash Flow | $-4,230 | $-7,640 | $50,710 | $58,150 | $37,800 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,100 | 1,290 | 1,550 | 1,260 | 600 |
| Financing Cash Flow | $2,100 | $1,290 | $1,550 | $1,260 | $600 |
| Exchange Rate Effect | -9 | -30 | 300 | 180 | 360 |
| Beginning Cash Position | 43,210 | 43,210 | 30,180 | 30,180 | 30,180 |
| End Cash Position | 38,600 | 30,630 | 43,210 | 64,150 | 47,780 |
| Net Cash Flow | $-4,610 | $-12,580 | $13,030 | $33,960 | $17,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,470 | -6,200 | -39,550 | -25,630 | -21,180 |
| Free Cash Flow | -2,470 | -6,200 | -39,550 | -25,630 | -21,180 |